LB abstract L06: Genovese et al. Filgotinib (JAK1-i) for treatment of RA after biologic failure. ACR 20/50/70 = 70/46/32% by 24 weeks. No GI perforations seen. #ACR18 @RheumNow https://t.co/5rAqz7ljXO
Links:
Dropbox - Genovese_ACR_2018_FINCH_2_Poster__final_10-19-18.pdf - Simplify your …
https://www.dropbox.com/s/om1mimk00dbtnzz/Genovese_ACR_2018_FINCH_2_Poster__fin…
Oct-24-2018
